What is the likely cause and recommended evaluation for a persistent rough patch on the palate lasting several months in a patient with a long history of inhaled and nasal steroid use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Persistent Rough Patch on Palate in Long-Term Inhaled Steroid User

This persistent rough palate lesion is most likely steroid-induced mucosal changes (including potential leukoplakia) from chronic inhaled corticosteroid deposition, and requires immediate direct laryngoscopy and oral cavity examination to exclude malignancy or severe candidiasis before any treatment modifications.

Most Likely Etiology

The chronic use of inhaled and nasal corticosteroids directly causes oropharyngeal mucosal changes that manifest as rough patches, leukoplakia, mucosal thickening, erythema, and granulation tissue 1. These changes result from:

  • Chemical laryngopharyngitis from topical steroid deposition in the oropharynx, which creates a spectrum of mucosal findings ranging from mild edema to frank leukoplakia 1
  • Increased candidiasis risk, with inhaled corticosteroids causing a 3-5 fold increased risk of oral candidiasis depending on delivery device (metered-dose inhalers carry higher risk than dry-powder inhalers) 2
  • Dose-dependent mucosal injury, as oropharyngeal adverse events increase significantly with higher corticosteroid doses regardless of device type 2

Critical Diagnostic Imperative

Direct visualization of the lesion via laryngoscopy and oral examination is mandatory before any empiric treatment 3. This is non-negotiable because:

  • A non-healing oral lesion lasting months requires tissue diagnosis to exclude squamous cell carcinoma or premalignant dysplasia 1
  • Steroid-induced leukoplakia can mimic malignant lesions and requires biopsy for definitive diagnosis 1
  • Esophageal candidiasis can occur even in immunocompetent patients on inhaled steroids, and a palatal lesion may represent extension of more severe disease 4

Specific Examination Findings to Document

When examining this patient, specifically assess for:

  • Leukoplakia (white patches that cannot be scraped off), mucosal thickening, erythema, or granulation tissue 1
  • Candidal plaques (white patches that can be removed, revealing erythematous base) 2, 5
  • Laryngeal involvement including vocal cord edema or thickening, as steroid inhaler laryngitis commonly coexists with oral findings 1
  • Concurrent laryngopharyngeal reflux signs, as patients with more severe steroid-induced mucosal findings are more likely to have reflux disease as a contributing factor 1

Management Algorithm

Step 1: Obtain Tissue Diagnosis

  • Perform biopsy of the rough patch to exclude malignancy or dysplasia 1
  • Culture for Candida species if clinical appearance suggests fungal infection 2, 4

Step 2: If Benign Steroid-Induced Changes Confirmed

  • Discontinue or reduce inhaled corticosteroid dose when medically feasible, as resolution only occurs after stopping the causative agent 1
  • If asthma control requires continued inhaled steroids, implement risk-reduction strategies:
    • Switch from metered-dose inhaler to dry-powder inhaler (reduces oropharyngeal deposition and candidiasis risk from 5-fold to 3-fold) 2
    • Mandatory post-dose mouth rinsing with water 2, 5
    • Use spacer device with metered-dose inhalers to reduce oropharyngeal drug deposition 2, 5

Step 3: Treat Candidiasis if Present

  • Initiate antifungal therapy (fluconazole for 2-4 weeks) if candidiasis confirmed 4
  • Consider esophagogastroduodenoscopy if dysphagia or odynophagia present, as esophageal candidiasis can occur even in immunocompetent inhaled steroid users 4

Step 4: Address Laryngopharyngeal Reflux

  • Treat concurrent reflux disease if present, as it exacerbates steroid-induced mucosal injury 1

Critical Pitfalls to Avoid

  • Never empirically treat without visualization - the American Academy of Otolaryngology explicitly recommends against empiric corticosteroid therapy (or any therapy) for oral/laryngeal symptoms without direct examination 3
  • Do not assume benignity - a non-healing lesion lasting months requires tissue diagnosis regardless of steroid use history 1
  • Do not overlook systemic immunosuppression - while local steroid effects are most likely, verify immune competence if candidiasis is severe or recurrent 4
  • Recognize that longer steroid duration increases risk - duration of inhaled corticosteroid use directly correlates with hoarseness, throat irritation, and mucosal changes 6

References

Research

Steroid inhaler laryngitis: dysphonia caused by inhaled fluticasone therapy.

Archives of otolaryngology--head & neck surgery, 2002

Research

Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2007

Guideline

clinical practice guideline: hoarseness (dysphonia) (update).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2018

Research

Esophageal candidiasis as a complication of inhaled corticosteroids.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.